← Back to headlines
US FDA Staff Highlights Peptide Risks, Citing Lack of Benefit Evidence
US FDA staff have highlighted potential risks associated with peptides, stating there is little evidence to support their claimed benefits.
30 Jun, 12:53 — 30 Jun, 12:53
Sources
Showing 1 of 1 sources
